Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$5.36M | -24.1K | -0.43% | $222.18 | 5.55M | Dec 28, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$3.69M | -16.8K | -0.3% | $220.16 | 5.54M | Dec 29, 2021 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.395 to $229.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.635 to $221.125. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |